News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,658 Results
Type
Article (45747)
Company Profile (330)
Press Release (714563)
Multimedia
Podcasts (126)
Webinars (22)
Section
Business (212583)
Career Advice (2122)
Deals (36578)
Drug Delivery (138)
Drug Development (82797)
Employer Resources (177)
FDA (17078)
Job Trends (15449)
News (357882)
Policy (33638)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2750)
Accelerated approval (48)
Adcomms (26)
Allergies (176)
Alliances (52624)
ALS (214)
Alzheimer's disease (1832)
Antibody-drug conjugate (ADC) (469)
Approvals (17458)
Artificial intelligence (726)
Autoimmune disease (302)
Automation (58)
Bankruptcy (367)
Best Places to Work (11929)
BIOSECURE Act (20)
Biosimilars (225)
Biotechnology (216)
Bladder cancer (201)
Brain cancer (73)
Breast cancer (767)
Cancer (5942)
Cardiovascular disease (480)
Career advice (1805)
Career pathing (43)
CAR-T (346)
CDC (58)
Celiac Disease (3)
Cell therapy (937)
Cervical cancer (47)
Clinical research (71731)
Collaboration (2164)
Company closure (6)
Compensation (1419)
Complete response letters (81)
COVID-19 (2831)
CRISPR (116)
C-suite (1175)
Cystic fibrosis (158)
Data (8033)
Decentralized trials (3)
Denatured (45)
Depression (164)
Dermatology (88)
Diabetes (592)
Diagnostics (7227)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (340)
Drug pricing (204)
Drug shortages (33)
Duchenne muscular dystrophy (291)
Earnings (93857)
Editorial (67)
Employer branding (22)
Employer resources (157)
Events (124552)
Executive appointments (1120)
FDA (20894)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1796)
Gene editing (251)
Generative AI (63)
Gene therapy (762)
GLP-1 (1077)
Government (4841)
Grass and pollen (7)
Guidances (411)
Healthcare (19738)
HIV (83)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (294)
Immuno-oncology (95)
Indications (196)
Infectious disease (3182)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (140)
Intellectual property (300)
Interviews (331)
IPO (17015)
IRA (51)
Job creations (3836)
Job search strategy (1502)
JPM (62)
Kidney cancer (19)
Labor market (102)
Layoffs (580)
Leadership (41)
Legal (8177)
Liver cancer (102)
Longevity (32)
Lung cancer (771)
Lymphoma (432)
Machine learning (63)
Management (63)
Manufacturing (1083)
MASH (191)
Medical device (14696)
Medtech (14826)
Mergers & acquisitions (20831)
Metabolic disorders (1521)
mRNA (231)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (429)
Neuropsychiatric disorders (105)
Neuroscience (3371)
Neurotech (1)
NextGen: Class of 2026 (6854)
Non-profit (4668)
Now hiring (78)
Obesity (709)
Opinion (303)
Ovarian cancer (226)
Pain (259)
Pancreatic cancer (311)
Parkinson's disease (370)
Partnered (34)
Patents (615)
Patient recruitment (689)
Peanut (65)
People (61924)
Pharmaceutical (66)
Pharmacy benefit managers (32)
Phase 1 (22518)
Phase 2 (31575)
Phase 3 (23395)
Pipeline (8942)
Policy (328)
Postmarket research (2588)
Preclinical (9691)
Press Release (71)
Prostate cancer (309)
Psychedelics (54)
Radiopharmaceuticals (348)
Rare diseases (1098)
Real estate (6303)
Recruiting (70)
Regulatory (26081)
Reports (56)
Research institute (2556)
Resumes & cover letters (365)
Rett syndrome (39)
RNA editing (25)
RSV (89)
Schizophrenia (179)
Series A (304)
Series B (218)
Service/supplier (14)
Sickle cell disease (114)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (49)
Startups (3909)
State (2)
Stomach cancer (18)
Supply chain (128)
Tariffs (87)
The Weekly (78)
Vaccines (1141)
Venture capital (114)
Weight loss (458)
Women's health (131)
Worklife (20)
Date
Today (134)
Last 7 days (781)
Last 30 days (3625)
Last 365 days (30962)
2026 (13159)
2025 (30960)
2024 (36206)
2023 (41132)
2022 (52397)
2021 (56991)
2020 (55610)
2019 (48406)
2018 (36438)
2017 (33539)
2016 (33138)
2015 (39357)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (782)
Alabama (96)
Alaska (7)
Arizona (362)
Arkansas (16)
Asia (42428)
Australia (7072)
California (13577)
Canada (3811)
China (1384)
Colorado (579)
Connecticut (594)
Delaware (423)
Europe (93513)
Florida (2016)
Georgia (443)
Hawaii (3)
Idaho (65)
Illinois (1088)
India (91)
Indiana (612)
Iowa (24)
Japan (552)
Kansas (135)
Kentucky (53)
Louisiana (43)
Maine (76)
Maryland (1619)
Massachusetts (9787)
Michigan (396)
Minnesota (743)
Mississippi (7)
Missouri (156)
Montana (36)
Nebraska (29)
Nevada (147)
New Hampshire (91)
New Jersey (3567)
New Mexico (31)
New York (3544)
North Carolina (1747)
North Dakota (11)
Northern California (6780)
Ohio (411)
Oklahoma (25)
Oregon (45)
Pennsylvania (2714)
Puerto Rico (30)
Rhode Island (51)
South America (1170)
South Carolina (87)
South Dakota (2)
Southern California (5365)
Tennessee (217)
Texas (2178)
United States (48100)
Utah (409)
Vermont (1)
Virginia (331)
Washington D.C. (81)
Washington State (1093)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
760,658 Results for "theralase technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theralase(R) Closes C$4.8 Million Offering
May 20, 2026
·
8 min read
Press Releases
Theralase(R) Announces $4 Million Brokered LIFE Offering
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
May 6, 2026
·
6 min read
Press Releases
Theralase(R) Investor Conference Call Reminder
Theralase(R) Reminds Investors of Conference Call to Provide Update on Study II Interim Data Demonstrating 64.3% Complete Response
November 17, 2025
·
5 min read
Press Releases
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
This Press Release identifies that Dr. Kulkarni has participated in a medical advisory position for Theralase(R) in the past.
February 20, 2026
·
8 min read
Press Releases
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
May 4, 2026
·
13 min read
Press Releases
Theralase(R) Closes $CAN 2.66 Million Financing
April 10, 2026
·
6 min read
Press Releases
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
April 13, 2026
·
6 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
·
1 min read
Press Releases
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
February 2, 2026
·
7 min read
1 of 76,066
Next
